Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Rascol

Showing results (141-150 of 220) with videos related to

Pageof 22
Sort By:
British Journal of Clinical Pharmacology|August 1, 1991
Subcutaneous apomorphine increases regional cerebral blood flow in parkinsonian patients via peripheral mechanismsU Sabatini, O Rascol, P Celsis, et al.
Brain : a Journal of Neurology|October 1, 1989
Abnormal ocular movements in Parkinson's disease. Evidence for involvement of dopaminergic systemsO Rascol, M Clanet, J L Montastruc, et al.
Annals of Neurology|January 5, 2002
Fluoxetine modulates motor performance and cerebral activation of patients recovering from strokeJ Pariente, I Loubinoux, C Carel, et al.
Clinical Neuropharmacology|February 1, 1993
Effects of yohimbine on plasma catecholamine levels in orthostatic hypotension related to Parkinson disease or multiple system atrophyJ M Senard, O Rascol, G Durrieu, et al.
Headache|March 17, 2001
Amitriptyline treatment in chronic drug-induced headache: a double-blind comparative pilot studyS Descombes, C Brefel-Courbon, C Thalamas, et al.
Clinical Neuropharmacology|October 1, 1991
Sublingual apomorphine in Parkinson's disease: a clinical and pharmacokinetic studyJ L Montastruc, O Rascol, J M Senard, et al.
Lancet (London, England)|February 27, 1993
Pseudophaeochromocytoma in parkinsonian patient treated with fluoxetine plus selegilineJ L Montastruc, B Chamontin, J M Senard, et al.
Revue Neurologique|January 1, 1988
[Effect of bromocriptine on cerebral blood flow in Parkinson's disease]P Celsis, O Rascol, J F Demonet, et al.
Clinical Neuropharmacology|June 8, 2001
Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic studyJ L Montastruc, C Brefel-Courbon, J M Senard, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 17, 2007
Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex studyA Gerdelat-Mas, M Simonetta-Moreau, C Thalamas, et al.
Pageof 22

Showing results (141-150 of 220) with videos related to

Sort By:
Pageof 22
British Journal of Clinical Pharmacology|August 1, 1991
Subcutaneous apomorphine increases regional cerebral blood flow in parkinsonian patients via peripheral mechanismsU Sabatini, O Rascol, P Celsis, et al.
Brain : a Journal of Neurology|October 1, 1989
Abnormal ocular movements in Parkinson's disease. Evidence for involvement of dopaminergic systemsO Rascol, M Clanet, J L Montastruc, et al.
Annals of Neurology|January 5, 2002
Fluoxetine modulates motor performance and cerebral activation of patients recovering from strokeJ Pariente, I Loubinoux, C Carel, et al.
Clinical Neuropharmacology|February 1, 1993
Effects of yohimbine on plasma catecholamine levels in orthostatic hypotension related to Parkinson disease or multiple system atrophyJ M Senard, O Rascol, G Durrieu, et al.
Headache|March 17, 2001
Amitriptyline treatment in chronic drug-induced headache: a double-blind comparative pilot studyS Descombes, C Brefel-Courbon, C Thalamas, et al.
Clinical Neuropharmacology|October 1, 1991
Sublingual apomorphine in Parkinson's disease: a clinical and pharmacokinetic studyJ L Montastruc, O Rascol, J M Senard, et al.
Lancet (London, England)|February 27, 1993
Pseudophaeochromocytoma in parkinsonian patient treated with fluoxetine plus selegilineJ L Montastruc, B Chamontin, J M Senard, et al.
Revue Neurologique|January 1, 1988
[Effect of bromocriptine on cerebral blood flow in Parkinson's disease]P Celsis, O Rascol, J F Demonet, et al.
Clinical Neuropharmacology|June 8, 2001
Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic studyJ L Montastruc, C Brefel-Courbon, J M Senard, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 17, 2007
Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex studyA Gerdelat-Mas, M Simonetta-Moreau, C Thalamas, et al.
Pageof 22